임상 레이더 AI | ||
|---|---|---|
임상시험 NCT05699642 (Mind2Move)은(는) 급성 관상동맥 증후군, 신체 비활동에 대해 모집중 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요. | ||
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰
Online Tai Chi Plus Fitbit After ACS (Mind2Move)
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '시험 설명하기'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT05699642 (Mind2Move)은(는) 기타을(를) 알아보기 위한 연구입니다. 이 연구는 급성 관상동맥 증후군, 신체 비활동에 대해 진행되며, 2상 중재연구으로 현재 상태는 모집중입니다. 연구는 2024년 8월 27일에 시작되어 70명의 참여자를 모집하고 있습니다. Beth Israel Deaconess Medical Center이(가) 진행하며, 2025년 11월 30일까지 완료될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2024년 9월 19일에 갱신되었습니다.
간단한 개요
This projects studies the role of tai chi exercise and wearable fitness trackers to promote physical activity in acute coronary syndrome (ACS) survivors.
상세한 설명
This is a two-site randomized controlled trial taking place at Beth Israel Deaconess Medical Center in Boston, MA and The Miriam Hospital in Providence, RI. Seventy (n=70) physically inactive ACS survivors will be randomized to either a 6-month group tai chi program (remotely-delivered classes on Zoom) integrated with a wearable self-monitoring/feedback device plus enhanced usual care (EUC), or to EUC alone. EUC will include usual care provided by participants' providers integrated with printed CHD risk factor education materials. Assessments will be conducted in-person at baseline, 6 months (end of treatment), and 9 months. Our primary outcomes will be focused on study feasibility and acceptability. Secondary outcomes include the following patient-centered outcomes: objectively measured (via accelerometry) moderate-vigorous physical activity, light physical activity, sedentary time, cognitive-behavioral constructs (exercise self-efficacy, intrinsic motivation, depression, stress, HRQL), and cardiometabolic measures (exercise capacity, body weight, lipid profile, blood pressure, fasting plasma glucose).
공식 제목
Tai Chi Exercise and Wearable Feedback Technology to Promote Physical Activity in Acute Coronary Syndrome Survivors
질환/상태
급성 관상동맥 증후군신체 비활동기타 연구 식별자
- Mind2Move
- 2022P000891
NCT 번호
실제 연구 시작일
2024-08-27
최신 업데이트 게시
2024-09-19
예상 연구 완료일
2025-11-30
계획된 등록 인원
70
연구종류
중재연구
단계/상
2상
상태
모집중
키워드
tai chi
fitness tracker
fitness tracker
주요 목적
기타
설계 할당
무작위배정
중재 모델
평행설계
맹검 (마스킹)
단일맹검
시험군 / 개입
| 참가자 그룹/시험군 | 개입/치료 |
|---|---|
실험적Tai chi + wearable 48 virtual tai chi classes on Zoom over 6 months plus assigned home practice of tai chi 3x a week plus daily use of a Fitbit fitness tracker will be required for this group. | Tai CHI + Wearable The tai chi intervention will be delivered remotely via Zoom Enterprise. Participants will access classes on a phone, tablet, laptop, or desktop computer. Participants will attend 3 classes/week (each lasting 60 min) during weeks 1-12, 2 classes/week during weeks 13-16, and then 1 class every other week during weeks 17-24. Classes include tai chi warm-up exercises, breathing exercises, review and practice of tai chi forms, and cool-down exercises. Participants will be asked to practice tai chi at home 3x per week during the 6 month intervention period using an instructional video provided to them. The Fitbit fitness tracker will be given to each participant along with instructions on how to use the tracker and the Fitbit app on their personal device. |
비개입Enhanced usual care Printed educational materials based on existing resources (e.g., AHA; Centers for Disease Control and Prevention) will be shared with subjects in this group. | 해당 없음 |
주요결과변수
이차결과변수
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
Recruitment rate | Recruitment rate will be evaluated with respect to rate of enrollment, defined as randomization into the trial. | Through study completion (an average of 3 years) |
Retention rate | Retention rate will be quantified by the proportion of subjects who remain in the study to complete our 9-month visit. | Through study completion (an average of 3 years) |
Intervention enjoyment | Intervention enjoyment will be assessed via qualitative interviews | 6 months |
Intervention adherence | Intervention adherence will be measured by collection of class attendance and home practice data. | Through study completion (an average of 3 years) |
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
Physical activity | Physical activity will be measured using accelerometers (Actigraph model wGT3X-BT, LLC, Fort Walton Beach, FL). | Baseline, 6 and 9 months |
Systolic and diastolic blood pressure | Blood pressure will be measured using a Dinamap XL automated BP monitor according to current recommendations. | Baseline, 6 and 9 months |
Body weight | Body weight will be measured using an electronic scale. | Baseline, 6 and 9 months |
Height | Height will be measured using a tape measure. | Baseline |
Fasting glucose | Fasting glucose will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. | Baseline, 6 and 9 months |
Lipid panel | Lipid panel will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. | Baseline, 6 and 9 months |
hs-CRP | hs-CRP will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. | Baseline, 6 and 9 months |
Quality of life assessed by SF-36 | Quality of life will be measured using a short version (8 items) of the Health Survey Short Form (SF-36). Scores range from 0-100, with a higher score indicating a higher quality of life. | Baseline, 6 and 9 months |
Intrinsic motivation | Intrinsic Motivation Inventory is a 22-item scale validated with four sub-scales: interest/enjoyment, perceived competence, perceived choice, and pressure/tension. A higher score is better, with a scoring range of 22-154. | Baseline, 6 and 9 months |
Anxiety, Depression | Anxiety, Depression will be assessed using the Hospital Anxiety and Depression Scale, a self-administered questionnaire with two sub-scales (0-21) measuring anxiety and depression, with higher scores indicating greater psychological morbidity. | Baseline, 6 and 9 months |
Stress | Stress will be measured using the Perceived Stress Scale (PSS) - a 10 items survey with scores ranging from 0 to 40, and higher scores indicating greater stress burden. | Baseline, 6 and 9 months |
Mindful awareness | Mindful awareness will be assessed using the Five Facets of Mindfulness questionnaire (short form) a 15-item questionnaire that measures the five identified components of mindfulness meditation: observing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Scores ranges from 39-19, with a higher score being better. | Baseline, 6 and 9 months |
Exercise self-efficacy | Exercise self-efficacy will be measured using the Self-Efficacy for Exercise Scale. This is a 9-item validated scale from McAuley's original barriers scale. Scores range form 9-28, with a higher score meaning more self-efficacy. | Baseline, 6 and 9 months |
Exercise capacity | Exercise capacity will be assessed via the 6 min walk test (6MWT), a simple, safe and reliable first-line assessment of functional status that correlates with peak oxygen uptake. | Baseline, 6 and 9 months |
적격성 기준
연령대
성인, 노인
최소 연령
18 Years
참여 가능한 성별
전체
- History of ACS (unstable angina, NSTEMI, and STEMI, defined per current AHA/ACC criteria);
- Age ≥ 18;
- Being physically inactive (i.e., < 150 min/week of moderate-intensity aerobic PA);
- Absence of contraindications to physical exercise per the participant's provider evaluation;
- Access to a digital device with internet connection;
- Having an active email account and ability to check email at least weekly;
- Physician clearance to participate in low-moderate intensity exercise (tai chi), including a statement that there is no contraindication to exercise based on post-ACS stress test and other factors, as appropriate;
- English speaking
- Inability or unwillingness to give informed consent;
- Blood pressure >200/110 or orthostatic systolic blood pressure decrease >20 mmHg at the baseline visit;
- Uncontrolled/untreated atrial or ventricular arrhythmias or 3rd degree AV block;
- Within 3 months of a diagnosis of pericarditis or myocarditis;
- Medical conditions likely to limit lifespan to less than one year;
- New York Heart Association (NYHA) functional class IV;
- Severe cognitive impairment (BOMC >10);139
- Orthopedic problems prohibiting TC practice;
- Ongoing TC or other mind-body training (i.e., meditation, TC, or yoga) at least weekly;
- Current enrollment in cardiac rehabilitation;
- Untreated severe depression (PHQ>=20);
- Conditions likely to affect study compliance (i.e., moving out of study area, substance use, ongoing untreated psychosis);
- Symptoms of unstable cardiovascular disease (e.g., shortness of breath or chest pain at rest and/or Canadian Cardiovascular Society Angina Class III-IV)
Beth Israel Deaconess Medical CenterLifespan연구 책임자
Gloria Y. Yeh, 책임연구자, Principal Investigator, Beth Israel Deaconess Medical Center
연구 대표 연락처
연락처: Daniel Litrownik, BA, 617-754-1423, [email protected]
1 1개국에 임상시험 장소
Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States
Research Assistant, 연락처, 617-754-1428, [email protected]
모집중